Sep 12, 2023 / 12:50PM GMT
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity Analyst
Hi, everyone. Good morning. My name is Tejas Savant, I'm the Life Science Tools and Diagnostics analyst here at Morgan Stanley. It's my pleasure to host 10x Genomics. And speaking on behalf of the company, we are lucky to have Serge Saxonov, CEO; and Justin McAnear, CFO. Welcome, gents.
Before we get started, quickly important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, do reach out your sales rep.
Questions and Answers:
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity AnalystSo maybe, Serge, just to set the stage, so much has gone on over the last few months for 10x. What are some of the things you want to get across to the investor community? And what are you most proud of this year?
Serge Saxonov - 10x Genomics, Inc. - Co-Founder, CEO & Director
Yes. There has been a busy year, busy last few years, I would
Trustpilot
